Armata Pharmaceuticals, Inc. (OTC:ARMP)
Industry: Basic Materials

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections in the United States. The company develops its products using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company is also developing and advancing synthetic phage for treating diseases caused by pseudomonas aeruginosa. Armata Pharmaceuticals, Inc. is headquartered in Marina del Rey, California.

Current Quote*
Last: $3.957
Change: 0.077
Book: $2.263
Volume: 9,766

As Of: 02/25 12:36 ET
*Quotes delayed by 20min.

Graphs for ARMP

3 Month Graph

6 Month Graph

1 Year Graph